Glomerular permselectivity in early stages of overt diabetic nephropathy

被引:0
|
作者
Andersen, S
Blouch, K
Bialek, J
Deckert, M
Parving, HH
Myers, BD
机构
[1] Stanford Univ, Sch Med, Div Nephrol, Dept Med, Stanford, CA 94305 USA
[2] Steno Diabet Ctr, Copenhagen, Denmark
关键词
filtration barrier defect; nephropathic diabetes; proteinuria; ficol; albuminuria; immunoglobulinuria;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Impairment of glomerular size selectivity has been demonstrated by the dextran-sieving technique in nephropathic diabetics with heavy, but not mild proteinuria. The purpose of the present study was to determine whether such a barrier defect could be demonstrated with mild proteinuria by substituting Ficoll 70, a polysucrose, for dextran as a probe of the filtration barrier. Methods. Differential solute clearances were performed in 12 individuals with early diabetic nephropathy on two occasions: after 60 days of treatment with losartan 50 mg daily or a placebo. An uncharged preparation of nonreabsorbable Ficoll 70 was infused along with inulin. Fractional clearance (theta) of Ficoll of discrete size was determined after separating molecules in urine and plasma in narrow 2 Angstrom fractions over a 20 to 60 Angstrom radius interval by size exclusion high-performance liquid chromatography (HPLC). A hydrodynamic theory of hindered ficoll transport through water-filled pores was used to characterize the pore size distribution of the glomerular barrier. Results. The theta for Ficoll molecules with radii >50 Angstrom was selectively enhanced in placebo-treated diabetic nephropathy versus corresponding theta in healthy control subjects (N = 12). Computations revealed a lower distribution of glomerular pores that was unaltered in nephropathic diabetics. However, an upper distribution of large, shunt-like pores was more prominent, exceeding healthy controls by one order of magnitude in diabetic nephropathy (P = 0.01). A trend to lower theta for Ficoll in the 56 to 60 Angstrom radius range during losartan therapy is computed to have lowered the fraction of shunted filtrate by 26 to 44%, depending on whether glomerular pressure declined. The corresponding reduction in theta for endogenous albumin, IgG, and IgG(4) was by 19 to 23% (P < 0.05). Conclusion. Our findings suggest that shunt-like defects, partially reversible by angiotensin II blockade, are present early in the course of diabetic nephropathy. We estimate that such defects can account for immunoglobulinuria in this disorder. Additional impairment of either charge- or shape-selectivity must be invoked to explain the observed level of albuminuria, however.
引用
收藏
页码:2129 / 2137
页数:9
相关论文
共 50 条
  • [41] Efficacy and Safety Profile of Finerenone in the Management of Diabetic Nephropathy in Its Early Stages
    Zhang, Feng-Ping
    Jiang, Xia
    AMERICAN JOURNAL OF THERAPEUTICS, 2025, 32 (02) : e179 - e184
  • [42] Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice
    Xiao, Xiaoyan
    Ma, Bin
    Dong, Baojun
    Zhao, Peng
    Tai, Ningwen
    Chen, Li
    Wong, F. Susan
    Wen, Li
    JOURNAL OF AUTOIMMUNITY, 2009, 32 (02) : 85 - 93
  • [43] SYSTEMIC INFLAMMATION AS A FACTOR OF ANEMIA DEVELOPMENT IN PATIENTS WITH EARLY STAGES OF DIABETIC NEPHROPATHY
    Pchelin, Ivan
    Shishkin, Alexander
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 139 - 140
  • [44] Urine miRNAs: Potential biomarkers for monitoring progression of early stages of diabetic nephropathy
    Yang, Yeyi
    Xiao, Li
    Li, Jun
    Kanwar, Yashpal S.
    Liu, Fuyou
    Sun, Lin
    MEDICAL HYPOTHESES, 2013, 81 (02) : 274 - 278
  • [45] Urinary Markers of Glomerular Injury in Diabetic Nephropathy
    Cohen-Bucay, Abraham
    Viswanathan, Gautham
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2012, 2012
  • [46] Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy
    Yamamoto, Y
    Maeshima, Y
    Kitayama, H
    Kitamura, S
    Takazawa, Y
    Sugiyama, H
    Yamasaki, Y
    Makino, H
    DIABETES, 2004, 53 (07) : 1831 - 1840
  • [47] STEREOLOGICAL ESTIMATION OF GLOMERULAR-BASEMENT-MEMBRANE MATERIAL IN THE EARLY PHASE OF DIABETIC NEPHROPATHY
    OSTERBY, R
    BANGSTAD, HJ
    BERG, KJ
    DAHLJORGENSEN, K
    HANSSEN, KF
    HARTMAN, A
    NYBERG, G
    KIDNEY INTERNATIONAL, 1992, 41 (03) : 703 - 703
  • [48] Three year follow up of infants of diabetic mothers with overt diabetic nephropathy
    Biesenbach, G
    Grafinger, P
    DIABETES, 1999, 48 : A315 - A315
  • [49] GLOMERULAR PERMSELECTIVITY DURING DEVELOPMENT
    GOLDSMITH, DI
    JODORKOVSKY, RA
    SPITZER, A
    PEDIATRIC RESEARCH, 1981, 15 (04) : 693 - 693
  • [50] ACE gene polymorphism and the prognosis and treatment of overt diabetic nephropathy
    Egido, Jesus
    Ortiz, Alberto
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (09): : 472 - 473